Jesper Hoeiland insider trades

Open-market stock purchases and sales by Jesper Hoeiland, Director at Allarity Therapeutics, Inc, from SEC Form 4 filings since Jun 13, 2019.

Recent trades

DateStockTradeValue
Jan 7, 2026ALLR Allarity Therapeutics, IncBought (not open market)—

Companies traded

  • ALLR Allarity Therapeutics, Inc: other filings, last Jan 7, 2026
  • CNCE Concert Pharmaceuticals, Inc: other filings, last Mar 6, 2023
  • RDUS Radius Health, Inc: other filings, last Feb 20, 2020

Get free alerts when Jesper Hoeiland files a new trade →